Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Active not recruiting 67Recruiting 48Completed 32Not yet recruiting 13Terminated 4Suspended 4Withdrawn 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1CNS 1

Conditions

Head and Neck Neoplasms 1Glioma 1Glioblastoma 1

Interventions

pembrolizumab 19Magnetic Resonance Spectroscopy 14Specimen Handling 13Cyclophosphamide 11fludarabine 10Radiotherapy 9Biopsy 9atezolizumab 7Nivolumab 7Radiation 6Gemcitabine 5fludarabine phosphate 4aldesleukin 4Prednisone 4Paclitaxel 4Etoposide 4Cytarabine 4Cisplatin 4Carboplatin 4Blood Specimen Collection 4Bevacizumab 4ALT-803 4venetoclax 3lenvatinib 3avelumab 3X-Rays 3Vincristine 3Surveys and Questionnaires 3Rituximab 3Phantoms, Imaging 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Radiotherapy, Intensity-Modulated × 1 year × Clear all
NCT03953352 2026-04-15

GIRAFE

Institut Claudius Regaud

Phase NA Withdrawn
Head & Neck

Head and Neck Neoplasms

NCT06501911 2025-07-22

A Study of Bicalutamide With Brain Re-irradiation to Treat Recurrent/Progressive High Grade Glioma

University of Nebraska

Phase 1 Withdrawn
CNS

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡